Advanced Isolator Systems
Deploy controlled, validation-ready manufacturing environments without the cost and complexity of conventional cleanroom buildouts.
THE CELL MANUFACTURING INFRASTRUCTURE PLATFORM
CELLNOVA integrates modular production systems, in-chamber machine vision, recurring bioprocess inputs, quality infrastructure, and digital lifecycle operations into one scalable platform.
HARDWARE ESTABLISHES THE INSTALLED BASE.
THE LIFECYCLE CREATES THE PLATFORM.
01 — THE CATEGORY THESIS
CELLNOVA is building the modular production backbone for cell therapy and regenerative medicine.
The platform begins with mission-critical physical infrastructure, then compounds value through recurring inputs, quality services, operational data, and an expanding installed base.
02 — THE PLATFORM ARCHITECTURE
Each deployed system creates a long-term operating relationship. Each additional layer increases customer value, revenue durability, and platform intelligence.
Deploy controlled, validation-ready manufacturing environments without the cost and complexity of conventional cleanroom buildouts.
A reliable supply of critical inputs engineered to support consistent, traceable cell manufacturing across every production run.
Integrated quality and validation services designed to accelerate technology transfer, clinical readiness, and commercial scale-up.
Unify in-chamber machine vision, equipment, environmental, and batch data for process oversight, traceability, and predictive operations.
THE COMPOUNDING MODEL
03 — DIGITAL QUALITY INFRASTRUCTURE
In-chamber machine vision combines with equipment and environmental data to create a time-aligned record of the manufacturing process—supporting electronic batch records, deviation review, and quality oversight.
Machine vision supports process verification and QA review. It does not replace validated analytical, microbiological, identity, purity, potency, or release testing.
04 — APPLICATIONS
Every modality, development stage, and facility constraint requires a different infrastructure architecture. We begin with the manufacturing objective.
Flexible manufacturing units from process development through commercialization
↗02Controlled environments for stem cell, tissue engineering, and emerging modalities
↗03A modular path to compliant point-of-care and hospital-based cell production
↗04Multi-program infrastructure engineered for speed, flexibility, and utilization
↗05 — DELIVERY
One disciplined path across equipment, process, quality, and operations—built to reduce complexity and accelerate readiness.
Product, capacity, facility, and regulatory objectives
An integrated equipment, process, and quality architecture
Installation, commissioning, qualification, and training
Technology transfer, process onboarding, and production readiness
Consumables, quality services, and digital lifecycle support
06 — VALUE CREATION
CELLNOVA measures progress through operating milestones—not distant volume assumptions. The result is a business designed to convert technical execution into durable enterprise value.
START A PROJECT
Share your modality, development stage, and capacity target. Our team will define the infrastructure path forward.